Stephen Krieger: Determining Best Treatments in Multiple Sclerosis

Video

While having a number of choices to pick from when treating patients with multiple sclerosis can be advantageous there can also be challenges that need to be addressed by both doctors and patients

While having a number of choices to pick from when treating patients with multiple sclerosis can be advantageous there can also be challenges that need to be addressed by both doctors and patients

Speaking at the annual meeting of the American Academy of Neurology in Vancouver, Stephen Krieger, MD, Mount Sinai Hospital, said there is emerging data that could show a reverse of some of the damages of MS. Learning about clinical trials, and being there with a patient who is treated for the first time, Krieger said, is meaningful. “We could try things and be in studies that will benefit the patient, but it also benefits science,” he said.

He said there is a lot of interest in MS. “There are certainly more of us now than years ago, and that gives patients more opportunities to have MS-familiar doctors.”

Kreiger added with the broad aspects of MS could mean broad choices in treatment strategies. “I think we are going to see combined treatments of MS,” Krieger said. "I think it is going to get more complicated and more personalized."

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
Elizabeth Spencer, MD: Precision Medicine in Pediatric IBD
Anita Clayton, MD: Zuranolone for Postpartum Depression
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
© 2024 MJH Life Sciences

All rights reserved.